Your browser doesn't support javascript.
loading
Autophagy induction by Mycobacterium indicus pranii promotes Mycobacterium tuberculosis clearance from RAW 264.7 macrophages.
Singh, Bindu; Saqib, Mohd; Gupta, Ananya; Kumar, Pawan; Bhaskar, Sangeeta.
Afiliação
  • Singh B; Product Development Cell, National Institute of Immunology, New Delhi, Delhi, India.
  • Saqib M; Product Development Cell, National Institute of Immunology, New Delhi, Delhi, India.
  • Gupta A; Product Development Cell, National Institute of Immunology, New Delhi, Delhi, India.
  • Kumar P; Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India.
  • Bhaskar S; Product Development Cell, National Institute of Immunology, New Delhi, Delhi, India.
PLoS One ; 12(12): e0189606, 2017.
Article em En | MEDLINE | ID: mdl-29236768
ABSTRACT
Mycobacterium indicus pranii (MIP) is a potent vaccine candidate against tuberculosis (TB) as it has demonstrated significant protection in animal models of tuberculosis as well as in clinical trials. Higher protective efficacy of MIP against TB as compared to BCG provoked the efforts to gain insight into the molecular mechanisms underlying MIP mediated protection against Mycobacterium tuberculosis (M.tb). Autophagy, initially described as a cell survival mechanism during starvation, also plays a key role in host resistance to M.tb. Virulent mycobacteria like M.tb, suppresses host autophagy response to increase its survival in macrophages. Since mycobacterial species have been shown to vary widely in their autophagy-inducing properties, in the present study, we examined the autophagy inducing efficacy of MIP and its role in MIP-mediated protection against M.tb. MIP was found to be potent inducer of autophagy in macrophages. Induced autophagy was responsible for reversal of the phagosome maturation block and phagolysosome fusion inhibition in M.tb infected macrophages, which ultimately lead to significantly enhanced clearance of M.tb from the macrophages. This is an important study which further delineated the underlying mechanisms for significant immunotherapeutic activity observed in TB patients / animal models of tuberculosis, given MIP therapy along with chemotherapy.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autofagia / Mycobacterium Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autofagia / Mycobacterium Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article